Orphan Drugs Korean Pharmas’ Ticket To Global Success?

Amid limited resources and marketing capabilities, South Korean pharmas are increasingly opting for improved and orphan drugs as their ticket to major global markets. Several companies shared their varying strategies for international success during a recent symposium in Seoul.